Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06443203
Active, not recruiting Not applicable

Multimodal Prehabilitation in Colorectal Cancer Patients

NCT06443203 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2021-06-15
Last updated
2025-03-30

Condition(s) studied

Colon CancerPrehabilitation

Investigational drug(s) / intervention(s)

Trimodal prehabilitation

Trimodal prehabilitation: Trimodal prehabilitation program (4-week physical exercise before surgery, nutritional optimization, and psychological support) in patients undergoing ERAS colorectal resection for cancer

Study summary

Postoperative complications can occur in up to 50% of individuals undergoing colorectal resection and are associated with poor prognosis, increased costs, and lower health-related quality of life. Even in the absence of complications, after major surgery, patients reduce their physiological and functional capacity by 20-40% and show a higher level of fatigue for 6-8 weeks. Many of these negative effects can be decreased by applying specific ERAS (Enhanced Recovery After Surgery) programs which, by attenuating the neuro-endocrine response induced by surgical trauma, accelerate patients\' post-operative convalescence and facilitate their return to functional activities.

In this study, the research group hypothesizes that a prehabilitation program based on physical exercise, nutritional optimization and psychological support (trimodal) carried out by patients in the 4 weeks before elective colorectal resection surgery can determine: 1) better physical performance 8 weeks after surgery (measured by the 6-minute walk test), 2) a possible decrease in postoperative complications, and 3) a reduction in in-hospital (direct) and post-hospital discharge (indirect) costs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients of age \>18 years; * elective colorectal resection for colonic cancer. Exclusion Criteria: * metastatic disease; * severe walking impairments; * renal failure stage \>2; * ASA score \>3; * preoperative chemo-radiation therapy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Unità Operativa Qualità, Accreditamento, Ricerca organizzativa Ferrara Italy

More University Hospital of Ferrara trials in Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06443203 on ClinicalTrials.gov ↗ ← All trials in Italy